About MELAGENIX
MELAGENIX is a company based in Koln (Germany) founded in 2017 by Daniel Von Janowski, Georg Brunner, and Anton Strobe.. MELAGENIX has raised $8.92 million across 1 funding round from investors including BayBG Venture Capital and MIG Capital. MELAGENIX operates in a competitive market with competitors including Castle Biosciences, DermTech, AMLo Biosciences, Haut and Michelson Diagnostics, among others.
- Headquarter Koln, Germany
- Founders Daniel Von Janowski, Georg Brunner, Anton Strobe
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Neracare Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.92 M (USD)
in 1 rounds
-
Latest Funding Round
$8.92 M (USD), Series A
Mar 05, 2020
-
Investors
BayBG Venture Capital
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of MELAGENIX
MELAGENIX has successfully raised a total of $8.92M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.92 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $8.9M
-
First Round
First Round
(05 Mar 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2020 | Amount | Series A - MELAGENIX | Valuation | BayBG Venture Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MELAGENIX
MELAGENIX has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BayBG Venture Capital and MIG Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in series A to series B stages
|
Founded Year | Domain | Location | |
|
VC Firm funding companies in Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MELAGENIX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MELAGENIX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Melagenix Comparisons
Competitors of MELAGENIX
MELAGENIX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Biosciences, DermTech, AMLo Biosciences, Haut and Michelson Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Prognostic tests for early-stage melanoma detection are developed.
|
|
| domain | founded_year | HQ Location |
SaaS solutions using AI for skincare businesses are provided.
|
|
| domain | founded_year | HQ Location |
Develops and supplies VivoSight OCT scanners for non-invasive medical diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about MELAGENIX
When was MELAGENIX founded?
MELAGENIX was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is MELAGENIX located?
MELAGENIX is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.
Is MELAGENIX a funded company?
MELAGENIX is a funded company, having raised a total of $8.92M across 1 funding round to date. The company's 1st funding round was a Series A of $8.92M, raised on Mar 05, 2020.
What does MELAGENIX do?
Founded in 2017 in Cologne, Germany, MELAGENIX operates in the biotechnology sector, focusing on molecular diagnostics for oncology. RT-PCR-based assays are developed to detect melanoma and assess AJCC staging in patients at clinical trial stages I-III. Tumor-specific information is provided to support treatment decisions, with operations centered on advancing diagnostic tools for skin cancer management.
Who are the top competitors of MELAGENIX?
MELAGENIX's top competitors include DermTech, AMLo Biosciences and Castle Biosciences.
Who are MELAGENIX's investors?
MELAGENIX has 2 investors. Key investors include BayBG Venture Capital, and MIG Capital.